VAXCYTE Insider Jim Balances Big Sell‑Offs and Deep Buys Amid $500 M Capital Raise and Vaccine Pipeline Hype
VAXCYTE insiders, led by Wassil Jim, buy low and sell high—showing confidence in upcoming VAX‑31 data and a new $500M capital raise.
3 minutes to read